Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis-Reference-Cited by-同舟云学术

Effect of thrombocytopenia on treatment tolerability and outcome in patients with chronic HCV infection and advanced hepatic fibrosis

Published:2014-09 Issue:3 Volume:61 Page:482-491
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Maan Raoel,van der Meer Adriaan J.,Hansen Bettina E.,Feld Jordan J.,Wedemeyer Heiner,Dufour Jean-François,Zangneh Hooman F.,Lammert Frank,Manns Michael P.,Zeuzem Stefan,Janssen Harry L.A.,de Knegt Robert J.,Veldt Bart J.

Publisher

Elsevier BV

Subject

Hepatology

Reference39 articles.

1. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups;Poynard;Lancet,1997

2. Serum thrombopoietin levels are linked to liver function in untreated patients with hepatitis C virus-related chronic hepatitis;Giannini;J Hepatol,2002

3. Thrombocytopenia in chronic hepatitis C;Olariu;J Gastrointest Liver Dis,2010

4. Platelet production and destruction in liver cirrhosis;Pradella;J Hepatol,2011

5. Thrombocytopenia associated with chronic liver disease;Afdhal;J Hepatol,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Different impacts of common risk factors associated with thrombocytopenia in patients with hepatitis B virus and hepatitis C virus infection;Biomedical Journal;2021-09

2. Delayed‐phase thrombocytopenia in patients with coronavirus disease 2019 (COVID‐19);British Journal of Haematology;2020-06-18

3. Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19);2020-04-15

4. Improvement of platelet in thrombocytopenic HCV patients after treatment with direct-acting antiviral agents and its relation to outcome;Platelets;2020-04-06

5. Effect of direct‐acting antivirals on platelet‐associated immunoglobulin G and thrombocytopenia in hepatitis C virus‐related chronic liver disease;Liver International;2019-05-24